Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:1542  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 
This article has been cited by
1The use of nitrofurantoin for children with acute cystitis caused by extended-spectrum ?-lactamase–producing Escherichia coli
A. Kara,M.K. Gurgoze
Journal of Pediatric Urology.2019;15(4)378.e1
[DOI]
2Oral treatment options for patients with urinary tract infections caused by extended spectrum ßeta-lactamase (ESBL) producing Enterobacteriaceae
Nadeem Sajjad Raja
Journal of Infection and Public Health.2019;12(6)843
[DOI]
3Novel partners with colistin to increase its in vivo therapeutic effectiveness and prevent the occurrence of colistin resistance in NDM- and MCR-co-producing Escherichia coli in a murine infection model
Yang Yu,Timothy R Walsh,Run-Shi Yang,Mei Zheng,Meng-Chao Wei,Jonathan M Tyrrell,Yang Wang,Xiao-Ping Liao,Jian Sun,Ya-Hong Liu
Journal of Antimicrobial Chemotherapy.2018;12(6)843
[DOI]
4Exposure to sub-inhibitory ciprofloxacin and nitrofurantoin concentrations increases recA gene expression in uropathogenic Escherichia coli: The role of RecA protein as a drug target
Ághata Cardoso da Silva Ribeiro,Willames Marcos Brasileiro da Silva Martins,Adilson Aderito da Silva,Ana Cristina Gales,Daniela Gonçales Galasse Rando,Luciene Andrade da Rocha Minarini
European Journal of Pharmaceutical Sciences.2020;146(6)105268
[DOI]
5Community-Acquired Urinary Tract Infection byEscherichia coliin the Era of Antibiotic Resistance
Dong Sup Lee,Seung-Ju Lee,Hyun-Sop Choe
BioMed Research International.2018;2018(6)1
[DOI]
6Antimicrobial Surveillance for Bacterial Uropathogens in Ha’il, Saudi Arabia: A Five-Year Multicenter Retrospective Study
Abdulrahman S Bazaid,Amir Saeed,Abdulaziz Alrashidi,Abdulkarim Alrashidi,Khalid Alshaghdali,Sahar A Hammam,Talal Alreshidi,Munif Alshammary,Abdullah Alarfaj,Rawan Thallab,Abdu Aldarhami
Infection and Drug Resistance.2021;Volume 14(6)1455
[DOI]
7Genomic Surveillance of Ceftriaxone-Resistant Escherichia coli in Western New York Suggests the Extended-Spectrum ß-Lactamase blaCTX-M-27 Is Emerging on Distinct Plasmids in ST38
Heba H. Mostafa,Andrew Cameron,Samantha M. Taffner,Jun Wang,Adel Malek,Ghinwa Dumyati,Dwight J. Hardy,Nicole D. Pecora
Frontiers in Microbiology.2020;11(6)1455
[DOI]
8Impact of reflex fosfomycin susceptibility testing on the utilization of carbapenems for definitive extended-spectrum ß-lactamase Escherichia coli urinary tract infection treatment
Kevin Deemer,Jonathan Grey,Christopher Fronczek,Kerry Marr
American Journal of Health-System Pharmacy.2020;77(Supplement_4)S105
[DOI]
9Machine learning for identifying resistance features of Klebsiella pneumoniae using whole-genome sequence single nucleotide polymorphisms
Wenjia Liu,Nanjiao Ying,Qiusi Mo,Shanshan Li,Mengjie Shao,Lingli Sun,Lei Zhu
Journal of Medical Microbiology.2021;70(11)S105
[DOI]
10Retrospective assessment of antimicrobial stewardship initiative in outpatient use of ertapenem for uncomplicated extended spectrum beta lactamase Enterobacteriaceae urinary tract infections
Carrie P. Wong,Thomas Delate,Elizabeth Hudson,Julia K. Nguyen,Su-Jau Yang,Mariana Abraham
BMC Infectious Diseases.2021;21(1)S105
[DOI]
11Experience with fosfomycin in the treatment of complicated urinary tract infections caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae
Luka Bielen,Robert Likic
Therapeutic Advances in Infectious Disease.2019;6(1)204993611985888
[DOI]
12A rapid, antibiotic susceptibility test for multidrug-resistant, Gram-negative bacterial uropathogens using the biochemical assay, DETECT
Nicole Jackson,Clarissa A. Borges,Nicole J. Tarlton,Angel Resendez,Aubrianne K. Milton,Tara R. de Boer,Cheyenne R. Butcher,Niren Murthy,Lee W. Riley
Journal of Microbiological Methods.2021;182(1)106160
[DOI]
13A Strategy for Hospital Pharmacists to Control Antimicrobial Resistance (AMR) in Japan
Yukihiro Hamada,Fumiya Ebihara,Ken Kikuchi
Antibiotics.2021;10(11)1284
[DOI]
  Addresses 
  My Preferences 


JGID
What's new
Forthcoming Symposia
Submit articles
Email alerts
Join us
Most popular articles
Recommend this journal
Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008